A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression
Condition: Depressive Disorder Interventions: Drug: sulforaphane; Other: placedo; Drug: Escitalopram Sponsor: Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
Conditions: Anxious Depression; Depression Interventions: Drug: Escitalopram; Drug: Duloxetine Sponsor: University of Cincinnati Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
Conditions: Anxiety; Depressive Symptoms Interventions: Drug: Duloxetine; Drug: Escitalopram Sponsor: University of Cincinnati Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials
A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression
Condition: Depressive Disorder Interventions: Drug: sulforaphane; Other: placedo; Drug: Escitalopram Sponsor: Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
Conditions: Anxious Depression; Depression Interventions: Drug: Escitalopram; Drug: Duloxetine Sponsor: University of Cincinnati Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials